BioMAS Ltd. (BioMAS) is a pharmaceutical company engaged in the development of innovative pharmaceuticals. It is focused on the development of therapeutics based on two small tellurium compounds such as AS101 and SAS It aimed for the treatment of various conditions including: viral infections, skin disorders, malignancies and neurological disorders. The company provides new non-toxic AS101/SAS drugs and new therapeutic strategy which binds through Arg-Gly-Asp (RGD) mimetic drugs and this drugs are involved in both pre-clinical studies and clinical trials to treat various areas such as central nervous system, dermatological disorders and papilloma virus. The company has an license agreement with international pharmaceutical and biotech companies which are involved in cancer,CNS, anti-viral and dermatology disorder markets. The company is headquartered in Kfar Saba, Israel.

Street: 
20 Hataas Street
City: 
Kfar Saba
Postcode: 
44425
Federal State : 
Israel
WebSite: 
www.biomas-pharma.com
Fax: 
972-72-2204008

Company Index Score

Current Index Score Historical Index Score
  • BioMAS Ltd. currently scores 50 % in the index.
  • BioMAS Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • BioMAS Ltd. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets